Effects of a Multidisciplinary Outpatient Rehabilitation Program in Patients With Ehlers-Danlos Syndrome.
Primary Purpose
Ehlers-Danlos Syndrome
Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Rehabilitation
Sponsored by
About this trial
This is an interventional treatment trial for Ehlers-Danlos Syndrome focused on measuring Rehabilitation; Ehlers-Danlos syndrome; Quality of life; Physical capacity
Eligibility Criteria
Inclusion Criteria:
- EDS diagnosis.
- Inclusion in the rehabilitation program.
Exclusion Criteria:
- Absolute and relative cardio-vascular contraindications to rehabilitation.
- Other contraindications to exercise.
- Psychological contraindication (Beck questionnaire score ≥ 20)
Sites / Locations
- Clinique de la Mitterie
Arms of the Study
Arm 1
Arm Type
Other
Arm Label
EDS Patients
Arm Description
No intervention during the control period (9 weeks) and then experimental during the rehabilitation stage (9 weeks).
Outcomes
Primary Outcome Measures
Distance covered in the 6-minute walk test
Secondary Outcome Measures
Other data from the 6-minute walk test
Time of an endurance test on a cyclo-ergometer
Area swept by the gravity center during a balance test on a posturological platform
Four balance tests : bipodal with eyes open, bipodal with eyes closed and unipodal with eyes open on the two sides
Tampa scale for kinesiophobia (questionnaire)
Brief pain inventory (questionnaire)
Nijmegen questionnaire
Multidimensional fatigue inventory (questionnaire)
Medical outcome study short form 36 (questionnaire)
Hospital anxiety and depression scale (questionnaire)
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT04680793
Brief Title
Effects of a Multidisciplinary Outpatient Rehabilitation Program in Patients With Ehlers-Danlos Syndrome.
Official Title
Effects of a Multidisciplinary Outpatient Rehabilitation Program on Physical Capacity and Quality of Life in Patients With Ehlers-Danlos Syndrome.
Study Type
Interventional
2. Study Status
Record Verification Date
July 2022
Overall Recruitment Status
Completed
Study Start Date
September 22, 2020 (Actual)
Primary Completion Date
April 13, 2022 (Actual)
Study Completion Date
April 13, 2022 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Hakimi Adrien
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The management of patients with Ehlers-Danlos syndrome (EDS) is still underdeveloped in healthcare institutions in France. Although multidisciplinary management through exercise rehabilitation has demonstrated its benefits in many chronic pathologies, it has not been evaluated for EDS. As a result, to date there is no evidence of its effectiveness in patients with EDS. The objective of this study is therefore to objectively evaluate the effectiveness of such a treatment on the different dimensions of these patients' health.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Ehlers-Danlos Syndrome
Keywords
Rehabilitation; Ehlers-Danlos syndrome; Quality of life; Physical capacity
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
Patients are assessed 9 weeks before the start of the program, at the beginning and at the end of the program, and 6 weeks and 6 months after the end of the program. The 9-week period before the program is used as a control condition. It is of the same duration as the program, which also lasts 9 weeks. Patients are asked not to change their lifestyle during the 9-week period before the rehabilitation program.
Masking
None (Open Label)
Allocation
N/A
Enrollment
25 (Actual)
8. Arms, Groups, and Interventions
Arm Title
EDS Patients
Arm Type
Other
Arm Description
No intervention during the control period (9 weeks) and then experimental during the rehabilitation stage (9 weeks).
Intervention Type
Other
Intervention Name(s)
Rehabilitation
Intervention Description
The program takes place over a total period of 9 weeks: for 4 weeks they will be cared for two days a week, then after a week's break, for 4 weeks they will be cared for three days a week for a total of approximately 80 hours of care. The program is multidisciplinary and includes: balneotherapy, ergometry, occupational therapy, gymnastics, physiotherapy, walking, sophrology, yoga as well as different workshops for the therapeutic education of the patient led by several professionals (dieticians, physiotherapists, doctors, psychologists).
Primary Outcome Measure Information:
Title
Distance covered in the 6-minute walk test
Time Frame
9 weeks before baseline ; Baseline ; 9 weeks ; 15 weeks ; 8 months
Secondary Outcome Measure Information:
Title
Other data from the 6-minute walk test
Time Frame
9 weeks before baseline ; Baseline ; 9 weeks ; 15 weeks ; 8 months
Title
Time of an endurance test on a cyclo-ergometer
Time Frame
Baseline ; 9 weeks
Title
Area swept by the gravity center during a balance test on a posturological platform
Description
Four balance tests : bipodal with eyes open, bipodal with eyes closed and unipodal with eyes open on the two sides
Time Frame
9 weeks before baseline ; Baseline ; 9 weeks ; 15 weeks ; 8 months
Title
Tampa scale for kinesiophobia (questionnaire)
Time Frame
9 weeks before baseline ; Baseline ; 9 weeks ; 15 weeks ; 8 months
Title
Brief pain inventory (questionnaire)
Time Frame
9 weeks before baseline ; Baseline ; 9 weeks ; 15 weeks ; 8 months
Title
Nijmegen questionnaire
Time Frame
9 weeks before baseline ; Baseline ; 9 weeks ; 15 weeks ; 8 months
Title
Multidimensional fatigue inventory (questionnaire)
Time Frame
9 weeks before baseline ; Baseline ; 9 weeks ; 15 weeks ; 8 months
Title
Medical outcome study short form 36 (questionnaire)
Time Frame
9 weeks before baseline ; Baseline ; 9 weeks ; 15 weeks ; 8 months
Title
Hospital anxiety and depression scale (questionnaire)
Time Frame
9 weeks before baseline ; Baseline ; 9 weeks ; 15 weeks ; 8 months
10. Eligibility
Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
EDS diagnosis.
Inclusion in the rehabilitation program.
Exclusion Criteria:
Absolute and relative cardio-vascular contraindications to rehabilitation.
Other contraindications to exercise.
Psychological contraindication (Beck questionnaire score ≥ 20)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Patrick MUCCI, Prof.
Organizational Affiliation
URePSSS
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Cyrille BERGOIN, Dr.
Organizational Affiliation
Clinique de la Mitterie
Official's Role
Principal Investigator
Facility Information:
Facility Name
Clinique de la Mitterie
City
Lomme
ZIP/Postal Code
59160
Country
France
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
35941284
Citation
Hakimi A, Bergoin C, Mucci P. Evidence of ventilatory constraints during exercise in hypermobile Ehlers-Danlos syndrome. Eur J Appl Physiol. 2022 Nov;122(11):2367-2374. doi: 10.1007/s00421-022-05017-y. Epub 2022 Aug 8.
Results Reference
derived
Learn more about this trial
Effects of a Multidisciplinary Outpatient Rehabilitation Program in Patients With Ehlers-Danlos Syndrome.
We'll reach out to this number within 24 hrs